Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Milosevic

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Hematology|December 23, 2011
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesAna Puda, Jelena D Milosevic, Tiina Berg, et al.
Blood|December 25, 2013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesElisa Rumi, Daniela Pietra, Virginia Ferretti, et al.
Heart (British Cardiac Society)|May 27, 2019
Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary interventionDragan M Matic, Milika R Asanin, Vladan D Vukcevic, et al.
Blood|May 9, 2019
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasmsFiorella Schischlik, Roland Jäger, Felix Rosebrock, et al.
Blood|November 18, 2015
Germline RBBP6 mutations in familial myeloproliferative neoplasmsAshot S Harutyunyan, Roberto Giambruno, Christian Krendl, et al.
American Journal of Hematology|February 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasmsDaniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, et al.
Plos One|October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
Leukemia|February 24, 2018
Chromothripsis in acute myeloid leukemia: biological features and impact on survivalMaria Chiara Fontana, Giovanni Marconi, Jelena D Milosevic Feenstra, et al.
American Journal of Hematology|August 14, 2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemiaJelena D Milosevic, Ana Puda, Luca Malcovati, et al.
The New England Journal of Medicine|December 12, 2013
Somatic mutations of calreticulin in myeloproliferative neoplasmsThorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|December 23, 2011
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesAna Puda, Jelena D Milosevic, Tiina Berg, et al.
Blood|December 25, 2013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesElisa Rumi, Daniela Pietra, Virginia Ferretti, et al.
Heart (British Cardiac Society)|May 27, 2019
Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary interventionDragan M Matic, Milika R Asanin, Vladan D Vukcevic, et al.
Blood|May 9, 2019
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasmsFiorella Schischlik, Roland Jäger, Felix Rosebrock, et al.
Blood|November 18, 2015
Germline RBBP6 mutations in familial myeloproliferative neoplasmsAshot S Harutyunyan, Roberto Giambruno, Christian Krendl, et al.
American Journal of Hematology|February 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasmsDaniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, et al.
Plos One|October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
Leukemia|February 24, 2018
Chromothripsis in acute myeloid leukemia: biological features and impact on survivalMaria Chiara Fontana, Giovanni Marconi, Jelena D Milosevic Feenstra, et al.
American Journal of Hematology|August 14, 2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemiaJelena D Milosevic, Ana Puda, Luca Malcovati, et al.
The New England Journal of Medicine|December 12, 2013
Somatic mutations of calreticulin in myeloproliferative neoplasmsThorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, et al.
Pageof 6